Correction: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants
Correction of earlier press release published today: The previous press release stated that the investor presentation took place on May 4, which was an error. It has now been corrected to May 26.COPENHAGEN, Denmark, 24 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby invites shareholders and warrant holders to a presentation and Q/A session regarding the ongoing warrant exercise period.In connection with the exercise period of DanCann Pharma’s warrants of series TO 2 the Company invite shareholders and warrant